| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-APOL3 (1-331) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
APOL3 |
| Gene ID: |
80833 |
| Uniprot ID: |
APOL3_HUMAN |
| Immunogen Region: |
1-331 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-331 of human APOL3 (NP_663614.1). |
| Immunogen Sequence: |
MDSEKKRFTEEATKYFRERV SPVHLQILLTNNEAWKRFVT AAELPRDEADALYEALKKLR TYAAIEDEYVQQKDEQFREW FLKEFPQVKRKIQESIEKLR ALANGIEEVHRGCTISNVVS SSTGAASGIMSLAGLVLAPF TAGTSLALTAAGVGLGAASA VTGITTSIVEHSYTSSAEAE ASRLTATSIDRLKVFKEVMR DITPNLLSLLNNYYEATQTI GSEIRAIRQARARARLPVT |
| Tissue Specificity | Widely expressed.the highest levels are in prostate, lung and placenta.also detected in kidney, bone marrow, spleen, thymus, spinal cord, adrenal gland, salivary gland, trachea and mammary gland.levels are low in brain, heart, fetal liver, pancreas and testis. |
| Function | May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles. |
| Protein Name | Apolipoprotein L3Apolipoprotein L-IiiApol-IiiTnf-Inducible Protein Cg12-1Cg12_1 |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-Apolipoprotein L3 antibodyAnti-Apolipoprotein L-Iii antibodyAnti-Apol-Iii antibodyAnti-Tnf-Inducible Protein Cg12-1 antibodyAnti-Cg12_1 antibodyAnti-APOL3 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
